Respiratory Syncytial Virus (RSV) Testing Market 2021: US, Europe, Japan--Supplier Shares, Sales Forecasts, Innovative Technologies, Competitive Strategies, Emerging Opportunities
The report presents a detailed analysis of the Respiratory Syncytial Virus diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Respiratory Syncytial Virus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:
-Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Respiratory Syncytial Virus tests.
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 227 pages and 15 tables
II. Worldwide Test Overview,
Technologies and Instrumentation
A. Background, Diagnostic Tests, Vaccines and Drugs
B. Instrumentation Review: Operating Characteristics,
Features and Selling Princes of Leading Infectious Disease
Automated and Semi-automated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
D. Personal Testing
III. Country Analyses: Sales and Volume Forecasts
IV. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
V. Design Criteria for Decentralized Testing Products
VI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
VII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VIII. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher/Life Technology
- Wallac/PE
- Wako
Global Respiratory Disease Diagnostics Market 2023-2029
The global respiratory disease diagnostics market is likely to register a CAGR of over 7.7% with an incremental growth of USD 4.4 billion during the forecast period 2023-2029.The report covers
USD 3050 View Report2022 whats Next for Europe Infectious Disease Testing Market in 38 Countries?--Supplier Shares by Test, Volume and Sales Segmentation Forecasts for 100 Respiratory, STD, Enteric, and other Virology and Bacteriology Assays--Competitive Strategies and SWOT Analysis, Latest Technologies, Instrumentation Pipeline, Market Barriers and Risks
This unique report from LeadingMarketResearch.com provides data and analysis not available from any other published source, including test volume and sales forecasts for 100 individual tests, and competitor strategies. The
USD 24500 View ReportGlobal Human Respiratory Syncytial Virus Drugs Market Research Report
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Human Respiratory Syncytial Virus Drugs Report by Material, Application, and Geography
USD View ReportRespiratory Syncytial Virus (RSV) Infections (Infectious Disease) - Drugs in Development, 2021
Respiratory Syncytial Virus (RSV) Infections (Infectious Disease) - Drugs in Development, 2021Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Respiratory Syncytial Virus Infections - Drugs In Development, 2021,
USD 2500 View ReportFill The Form For Sample Request